Forte Biosciences, Inc. (FBRX) › Operating IncomeForte Biosciences, Inc. (FBRX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2015: -$22.95M2016: -$31.69M2017: -$37.63M2018: -$45.85M2019: -$4.06M2020: -$46.28M2021: -$21.49M2022: -$13.90M2023: -$32.49M2024: -$36.60M2025: -$70.66M-$70.66M2015Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$70.66M-93.0%2024-$36.60M-12.7%2023-$32.49M-133.8%2022-$13.90M+35.3%2021-$21.49M+53.6%2020-$46.28M-1038.8%2019-$4.06M+91.1%2018-$45.85M-21.9%2017-$37.63M-18.7%2016-$31.69M-38.1%2015-$22.95M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share